154 related articles for article (PubMed ID: 37415171)
1. Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop.
Wang Y; Wang X; Wang K; Qi J; Zhang Y; Wang X; Zhang L; Zhou Y; Gu L; Yu R; Zhou X
J Exp Clin Cancer Res; 2023 Jul; 42(1):161. PubMed ID: 37415171
[TBL] [Abstract][Full Text] [Related]
2. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
3. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.
Caragher SP; Shireman JM; Huang M; Miska J; Atashi F; Baisiwala S; Hong Park C; Saathoff MR; Warnke L; Xiao T; Lesniak MS; James CD; Meltzer H; Tryba AK; Ahmed AU
J Neurosci; 2019 Mar; 39(11):1982-1993. PubMed ID: 30651332
[TBL] [Abstract][Full Text] [Related]
4. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis.
Lee H; Shim S; Kong JS; Kim MJ; Park S; Lee SS; Kim A
Cancer Sci; 2021 Sep; 112(9):3732-3743. PubMed ID: 34118099
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.
Jeon HM; Oh YT; Shin YJ; Chang N; Kim D; Woo D; Yeup Y; Joo KM; Jo H; Yang H; Lee JK; Kang W; Sa J; Lee WJ; Hale J; Lathia JD; Purow B; Park MJ; Park JB; Nam DH; Lee J
Neoplasia; 2023 May; 39():100894. PubMed ID: 36972629
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma.
Li J; Zhu S; Kozono D; Ng K; Futalan D; Shen Y; Akers JC; Steed T; Kushwaha D; Schlabach M; Carter BS; Kwon CH; Furnari F; Cavenee W; Elledge S; Chen CC
Oncotarget; 2014 Feb; 5(4):882-93. PubMed ID: 24658464
[TBL] [Abstract][Full Text] [Related]
8. β-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between β-arrestin2 and STAT3 in mouse model of depression.
Liu Y; Song N; Yao H; Jiang S; Wang Y; Zheng Y; Zhou Y; Ding J; Hu G; Lu M
J Neuroinflammation; 2022 Oct; 19(1):240. PubMed ID: 36183107
[TBL] [Abstract][Full Text] [Related]
9. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
10. The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.
Shi L; Chen H; Chen K; Zhong C; Song C; Huang Y; Wang T; Chen L; Li C; Huang A; Qi S; Li H; Lu Y
Clin Cancer Res; 2023 Aug; 29(16):3172-3188. PubMed ID: 37249604
[TBL] [Abstract][Full Text] [Related]
11. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract][Full Text] [Related]
12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
13. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
14. The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.
Weissenrieder JS; Reed JL; Green MV; Moldovan GL; Koubek EJ; Neighbors JD; Hohl RJ
Pharmacology; 2020; 105(1-2):19-27. PubMed ID: 31645049
[TBL] [Abstract][Full Text] [Related]
15. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway.
Nitta RT; Gholamin S; Feroze AH; Agarwal M; Cheshier SH; Mitra SS; Li G
Oncogene; 2015 Jul; 34(28):3688-99. PubMed ID: 25241897
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
18. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
19. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]